aminopropionitrile has been researched along with Progeria in 1 studies
Aminopropionitrile: Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.
Progeria: An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Kleeck, R | 1 |
| Roberts, E | 1 |
| Castagnino, P | 1 |
| Bruun, K | 1 |
| Brankovic, SA | 1 |
| Hawthorne, EA | 1 |
| Xu, T | 1 |
| Tobias, JW | 1 |
| Assoian, RK | 1 |
1 other study available for aminopropionitrile and Progeria
| Article | Year |
|---|---|
Arterial stiffness and cardiac dysfunction in Hutchinson-Gilford Progeria Syndrome corrected by inhibition of lysyl oxidase.
Topics: Aging, Premature; Aminopropionitrile; Animals; Disease Models, Animal; Female; Heart Diseases; Lamin | 2021 |